mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.3 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.3 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.05 |
0.3 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.3 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |